Mirxes XtalPi AI Platform Targets Asian GI Cancers
CompanyDeals

Mirxes XtalPi AI Platform Targets Asian GI Cancers

Sirnaomics ChemPartner GalAhead Nucleic-Acid Deal
CompanyDeals

Sirnaomics ChemPartner GalAhead Nucleic-Acid Deal

NHSA 2025 Drug Lists Add 114 Medical Insurance Drugs, 19 Commercial
Policy / Regulatory

NHSA 2025 Drug Lists Add 114 Medical Insurance Drugs, 19 Commercial

OTR Therapeutics Series-A Raises $100M for Neurology Pipeline
CompanyDeals

OTR Therapeutics Series-A Raises $100M for Neurology Pipeline

Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform
CompanyDeals

Sanofi Completes Vicebio $1.6B Acquisition, Adds RSV Vaccine Platform

Juventas CAR-T LBCL Launch Marks Second Indication
CompanyDrug

Juventas CAR-T LBCL Launch Marks Second Indication

BMS Breyanzi MZL FDA Approval First CAR-T
CompanyDrug

BMS Breyanzi MZL FDA Approval First CAR-T

Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient
CompanyDeals

Formosa Pharma APP13007 Clobetasol ASEAN Deal with Rxilient

Novo Nordisk semaglutide Alzheimer's biomarkers fail primary endpoint
CompanyDrug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures
CompanyMedical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes
CompanyDeals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod
CompanyDrug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod